Literature DB >> 15231619

Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs.

Paul Dieppe1, Christopher Bartlett, Peter Davey, Lesley Doyal, Shah Ebrahim.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15231619      PMCID: PMC443450          DOI: 10.1136/bmj.329.7456.31

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  25 in total

1.  Using patient-identifiable data for observational research and audit.

Authors:  R Al-Shahi; C Warlow
Journal:  BMJ       Date:  2000-10-28

2.  Risk of myocardial infarction associated with selective COX-2 inhibitors: questions remain.

Authors:  Peter Jüni; Paul Dieppe; Matthias Egger
Journal:  Arch Intern Med       Date:  2002 Dec 9-23

Review 3.  Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint.

Authors:  J A Chard; D Tallon; P A Dieppe
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

4.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Authors:  R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe
Journal:  Arthritis Rheum       Date:  1998-05

Review 5.  The causes and effects of socio-demographic exclusions from clinical trials.

Authors:  C Bartlett; L Doyal; S Ebrahim; P Davey; M Bachmann; M Egger; P Dieppe
Journal:  Health Technol Assess       Date:  2005-10       Impact factor: 4.014

6.  Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

Authors:  J Page; D Henry
Journal:  Arch Intern Med       Date:  2000-03-27

7.  Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center.

Authors:  D L Huong; T Papo; H Beaufils; B Wechsler; O Blétry; A Baumelou; P Godeau; J C Piette
Journal:  Medicine (Baltimore)       Date:  1999-05       Impact factor: 1.889

8.  Exclusion of elderly people from clinical research: a descriptive study of published reports.

Authors:  G Bugeja; A Kumar; A K Banerjee
Journal:  BMJ       Date:  1997-10-25

Review 9.  Age and gender bias in statin trials.

Authors:  S Bandyopadhyay; A J Bayer; M S O'Mahony
Journal:  QJM       Date:  2001-03

10.  Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure.

Authors:  S Pérez Gutthann; L A García Rodríguez; D S Raiford; A Duque Oliart; J Ris Romeu
Journal:  Arch Intern Med       Date:  1996-11-25
View more
  15 in total

1.  Balancing benefits and harms in health care: ethical dimension was not discussed in theme issue.

Authors:  Richard E Ashcroft
Journal:  BMJ       Date:  2004-08-21

2.  Balancing benefits and harms in health care: technology to collect and share information about harms already exists.

Authors:  Paul L Cervi
Journal:  BMJ       Date:  2004-08-21

3.  Lessons from the withdrawal of rofecoxib.

Authors:  Paul A Dieppe; Shah Ebrahim; Richard M Martin; Peter Jüni
Journal:  BMJ       Date:  2004-10-16

4.  Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2005-06-11

5.  European Medicines Agency policies for clinical trials leave women unprotected.

Authors:  Maria Teresa Ruiz Cantero; Maria Angeles Pardo
Journal:  J Epidemiol Community Health       Date:  2006-11       Impact factor: 3.710

6.  Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice.

Authors:  Sally Hull; Rohini Mathur; Gavin Dreyer; Muhammad Magdi Yaqoob
Journal:  Br J Gen Pract       Date:  2014-07       Impact factor: 5.386

7.  A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs.

Authors:  E H Choy; G H Kingsley; B Khoshaba; N Pipitone; D L Scott
Journal:  Ann Rheum Dis       Date:  2005-03-10       Impact factor: 19.103

Review 8.  Special considerations with the use of intravenous immunoglobulin in older persons.

Authors:  M Jennifer Cheng; Colleen Christmas
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

9.  Evaluating medical effectiveness for the california health benefits review program.

Authors:  Harold S Luft; Karen M Rappaport; Edward H Yelin; Wade M Aubry
Journal:  Health Serv Res       Date:  2006-06       Impact factor: 3.402

Review 10.  The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.

Authors:  Lee Hooper; Tamara J Brown; Rachel Elliott; Katherine Payne; Chris Roberts; Deborah Symmons
Journal:  BMJ       Date:  2004-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.